This observational, multi-center study will evaluate the treatment regimen, treatment responses and safety of RoActemra/Actemra (tocilizumab) therapy in a routine clinical practice in patients with mo...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

This observational, multi-center study will evaluate the treatment regimen, treatment responses and safety of RoActemra/Actemra (tocilizumab) therapy in a routine clinical practice in patients with mo...

Condition : Ankylosing Spondylitis Intervention : Biological: Golimumab Sponsor : Merck Sharp & Dohme Corp. Recruiting - verified February 2014

Condition : Ankylosing Spondylitis Intervention : Biological: Golimumab Sponsor : Merck Recruiting - verified November 2013

Condition : Osteoarthritis Interventions : Biological: ABT-981; Biological: Placebo Sponsors : AbbVie; AbbVie (prior sponsor, Abbott) Completed - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Genentech Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Genentech Active, not recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013